ACR appropriateness criteria® posttreatment follow-up of prostate cancer

David D. Casalino, Erick M. Remer, Ronald S. Arellano, Jay T. Bishoff, Courtney A. Coursey, Manjiri Dighe, Douglas F. Eggli, Pat Fulgham, Gary M. Israel, Elizabeth Lazarus, John R. Leyendecker, Paul Nikolaidis, Nicholas Papanicolaou, Srinivasa Prasad, Parvati Ramchandani, Sheila Sheth, Raghunandan Vikram

Research output: Contribution to journalArticle

Abstract

Although prostate cancer can be effectively treated, recurrent or residual disease after therapy is not uncommon and is usually detected by a rise in prostate-specific antigen. Patients with biochemical prostate-specific antigen relapse should undergo a prompt search for the presence of local recurrence or distant metastatic disease, each requiring different forms of therapy. Various imaging modalities and image-guided procedures may be used in the evaluation of these patients. Literature on the indications and usefulness of these radiologic studies and procedures in specific clinical settings is reviewed. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Original languageEnglish (US)
Pages (from-to)863-871
Number of pages9
JournalJournal of the American College of Radiology
Volume8
Issue number12
DOIs
StatePublished - 2011

Fingerprint

Prostatic Neoplasms
Prostate-Specific Antigen
Guidelines
Recurrence
Expert Testimony
Therapeutics

Keywords

  • Appropriateness Criteria
  • imaging
  • posttreatment
  • prostate
  • prostate cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Casalino, D. D., Remer, E. M., Arellano, R. S., Bishoff, J. T., Coursey, C. A., Dighe, M., ... Vikram, R. (2011). ACR appropriateness criteria® posttreatment follow-up of prostate cancer. Journal of the American College of Radiology, 8(12), 863-871. https://doi.org/10.1016/j.jacr.2011.09.003

ACR appropriateness criteria® posttreatment follow-up of prostate cancer. / Casalino, David D.; Remer, Erick M.; Arellano, Ronald S.; Bishoff, Jay T.; Coursey, Courtney A.; Dighe, Manjiri; Eggli, Douglas F.; Fulgham, Pat; Israel, Gary M.; Lazarus, Elizabeth; Leyendecker, John R.; Nikolaidis, Paul; Papanicolaou, Nicholas; Prasad, Srinivasa; Ramchandani, Parvati; Sheth, Sheila; Vikram, Raghunandan.

In: Journal of the American College of Radiology, Vol. 8, No. 12, 2011, p. 863-871.

Research output: Contribution to journalArticle

Casalino, DD, Remer, EM, Arellano, RS, Bishoff, JT, Coursey, CA, Dighe, M, Eggli, DF, Fulgham, P, Israel, GM, Lazarus, E, Leyendecker, JR, Nikolaidis, P, Papanicolaou, N, Prasad, S, Ramchandani, P, Sheth, S & Vikram, R 2011, 'ACR appropriateness criteria® posttreatment follow-up of prostate cancer', Journal of the American College of Radiology, vol. 8, no. 12, pp. 863-871. https://doi.org/10.1016/j.jacr.2011.09.003
Casalino, David D. ; Remer, Erick M. ; Arellano, Ronald S. ; Bishoff, Jay T. ; Coursey, Courtney A. ; Dighe, Manjiri ; Eggli, Douglas F. ; Fulgham, Pat ; Israel, Gary M. ; Lazarus, Elizabeth ; Leyendecker, John R. ; Nikolaidis, Paul ; Papanicolaou, Nicholas ; Prasad, Srinivasa ; Ramchandani, Parvati ; Sheth, Sheila ; Vikram, Raghunandan. / ACR appropriateness criteria® posttreatment follow-up of prostate cancer. In: Journal of the American College of Radiology. 2011 ; Vol. 8, No. 12. pp. 863-871.
@article{8e8346c51dbd4654aa231dc74663fc6e,
title = "ACR appropriateness criteria{\circledR} posttreatment follow-up of prostate cancer",
abstract = "Although prostate cancer can be effectively treated, recurrent or residual disease after therapy is not uncommon and is usually detected by a rise in prostate-specific antigen. Patients with biochemical prostate-specific antigen relapse should undergo a prompt search for the presence of local recurrence or distant metastatic disease, each requiring different forms of therapy. Various imaging modalities and image-guided procedures may be used in the evaluation of these patients. Literature on the indications and usefulness of these radiologic studies and procedures in specific clinical settings is reviewed. The ACR Appropriateness Criteria{\circledR} are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.",
keywords = "Appropriateness Criteria, imaging, posttreatment, prostate, prostate cancer",
author = "Casalino, {David D.} and Remer, {Erick M.} and Arellano, {Ronald S.} and Bishoff, {Jay T.} and Coursey, {Courtney A.} and Manjiri Dighe and Eggli, {Douglas F.} and Pat Fulgham and Israel, {Gary M.} and Elizabeth Lazarus and Leyendecker, {John R.} and Paul Nikolaidis and Nicholas Papanicolaou and Srinivasa Prasad and Parvati Ramchandani and Sheila Sheth and Raghunandan Vikram",
year = "2011",
doi = "10.1016/j.jacr.2011.09.003",
language = "English (US)",
volume = "8",
pages = "863--871",
journal = "Journal of the American College of Radiology",
issn = "1558-349X",
publisher = "Elsevier BV",
number = "12",

}

TY - JOUR

T1 - ACR appropriateness criteria® posttreatment follow-up of prostate cancer

AU - Casalino, David D.

AU - Remer, Erick M.

AU - Arellano, Ronald S.

AU - Bishoff, Jay T.

AU - Coursey, Courtney A.

AU - Dighe, Manjiri

AU - Eggli, Douglas F.

AU - Fulgham, Pat

AU - Israel, Gary M.

AU - Lazarus, Elizabeth

AU - Leyendecker, John R.

AU - Nikolaidis, Paul

AU - Papanicolaou, Nicholas

AU - Prasad, Srinivasa

AU - Ramchandani, Parvati

AU - Sheth, Sheila

AU - Vikram, Raghunandan

PY - 2011

Y1 - 2011

N2 - Although prostate cancer can be effectively treated, recurrent or residual disease after therapy is not uncommon and is usually detected by a rise in prostate-specific antigen. Patients with biochemical prostate-specific antigen relapse should undergo a prompt search for the presence of local recurrence or distant metastatic disease, each requiring different forms of therapy. Various imaging modalities and image-guided procedures may be used in the evaluation of these patients. Literature on the indications and usefulness of these radiologic studies and procedures in specific clinical settings is reviewed. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

AB - Although prostate cancer can be effectively treated, recurrent or residual disease after therapy is not uncommon and is usually detected by a rise in prostate-specific antigen. Patients with biochemical prostate-specific antigen relapse should undergo a prompt search for the presence of local recurrence or distant metastatic disease, each requiring different forms of therapy. Various imaging modalities and image-guided procedures may be used in the evaluation of these patients. Literature on the indications and usefulness of these radiologic studies and procedures in specific clinical settings is reviewed. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

KW - Appropriateness Criteria

KW - imaging

KW - posttreatment

KW - prostate

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84928096343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928096343&partnerID=8YFLogxK

U2 - 10.1016/j.jacr.2011.09.003

DO - 10.1016/j.jacr.2011.09.003

M3 - Article

VL - 8

SP - 863

EP - 871

JO - Journal of the American College of Radiology

JF - Journal of the American College of Radiology

SN - 1558-349X

IS - 12

ER -